Cargando…

A Risk Model Composed of Complete Blood Count, BRAF V600E and MAP2K1 Predicts Inferior Prognosis of Langerhans Cell Histiocytosis in Children

BACKGROUND: In children, Langerhans cell histiocytosis (LCH), which is the most prevalent histiocytic disorder, exhibits a wide variety of manifestations and outcomes. There is no standard prognosis evaluation system for LCH. We investigated the combined predictive significance of complete blood cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Leyuan, Yuan, Lin, Du, Xizi, Zhou, Kai, Yang, Yu, Qin, Qingwu, Yang, Liangchun, Xiang, Yang, Qu, Xiangping, Liu, Huijun, Qin, Xiaoqun, Liu, Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854502/ https://www.ncbi.nlm.nih.gov/pubmed/35186740 http://dx.doi.org/10.3389/fonc.2022.800786

Ejemplares similares

BRAF V600E-Positive Congenital Multisite Langerhans Cell Histiocytosis
por: Prada Avella, Maria Camila, et al.
Publicado: (2020)

BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay
por: Tatsuno, Michiko, et al.
Publicado: (2016)

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate
por: Bates, Sara V., et al.
Publicado: (2013)

Lineage switching of the cellular distribution of BRAF(V600E) in multisystem Langerhans cell histiocytosis
por: Milne, Paul, et al.
Publicado: (2022)

Dabrafenib, alone or in combination with trametinib, in BRAF V600–mutated pediatric Langerhans cell histiocytosis
por: Whitlock, James A., et al.
Publicado: (2023)

Langerhans Cell Histiocytosis, Non-Langerhans histiocytosis and concurrent Papillary Thyroid Carcinoma with BRAF V600E mutations: A case report and literature review
por: Wake, Laura, et al.
Publicado: (2019)

Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAF(V600E)-Mutated Langerhans Cell Histiocytosis
por: Yang, Ying, et al.
Publicado: (2021)

Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation?
por: Moschovi, Maria, et al.
Publicado: (2015)

Clinicopathological features and BRAF(V600E) mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis
por: Huo, Zhen, et al.
Publicado: (2016)

Association between clinicopathologic characteristics and BRAF(V600E) expression in Chinese patients with Langerhans cell histiocytosis
por: Huang, Hui, et al.
Publicado: (2019)

A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children
por: Phan, Thu Dang Anh, et al.
Publicado: (2021)

Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAF(V600E)
por: Milne, Paul, et al.
Publicado: (2022)

Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
por: Cui, Lei, et al.
Publicado: (2020)

BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis
por: Nelson, David S., et al.
Publicado: (2019)

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis
por: Kudo, Ko, et al.
Publicado: (2022)

New somatic BRAF splicing mutation in Langerhans cell histiocytosis
por: Héritier, Sébastien, et al.
Publicado: (2017)

Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing
por: Feng, Shunqiao, et al.
Publicado: (2021)

Adult Onset of BRAF(V600E)-Mutated Langerhans Cell Histiocytosis with Cutaneous Involvement Successfully Diagnosed by Immunohistochemical Staining
por: Tono, Hisayuki, et al.
Publicado: (2015)

Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAF(V600E) mutations in adult populations
por: Selway, Joanne Louise, et al.
Publicado: (2017)

Multisystemic Pediatric Langerhans cell histiocytosis: a comprehensive clinico-pathological and BRAF V600E mutation study at autopsy
por: Kapatia, Gargi, et al.
Publicado: (2020)

BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis
por: Zeng, Kaixuan, et al.
Publicado: (2016)

Autologous hematopoietic stem cell transplantation for efficient treatment of multisystem, high-risk, BRAF V600E-negative Langerhans cell histiocytosis
por: Pan, Yaozhu, et al.
Publicado: (2019)

The DNA methylation of FOXO3 and TP53 as a blood biomarker of late-onset asthma
por: Yuan, Lin, et al.
Publicado: (2020)

Correction to: The DNA methylation of FOXO3 and TP53 as a blood biomarker of late-onset asthma
por: Yuan, Lin, et al.
Publicado: (2021)

miRNA‐34b/c regulates mucus secretion in RSV‐infected airway epithelial cells by targeting FGFR1
por: Li, Wenkai, et al.
Publicado: (2021)

ITGB4 deficiency in bronchial epithelial cells directs airway inflammation and bipolar disorder-related behavior
por: Han, Li, et al.
Publicado: (2018)

ITGB4 deficiency induces mucus hypersecretion by upregulating MUC5AC in RSV-infected airway epithelial cells
por: Du, Xizi, et al.
Publicado: (2022)

Langerhans cell histiocytosis
por: Aruna, D. R., et al.
Publicado: (2011)

Langerhans cell histiocytosis
por: Kumar, Manish, et al.
Publicado: (2018)

Aberrant Methylation of Aging-Related Genes in Asthma
por: Yang, Yu, et al.
Publicado: (2021)

ITGB4 Deficiency in Airway Epithelium Aggravates RSV Infection and Increases HDM Sensitivity
por: Du, Xizi, et al.
Publicado: (2022)

Variable DNA methylation of aging-related genes is associated with male COPD
por: Du, Xizi, et al.
Publicado: (2019)

BRAF Mutation Analysis in Two Cases of Congenital Self-Healing Langerhans Cell Histiocytosis
por: Takayama, Saki, et al.
Publicado: (2022)

Three decades of progress from surgery to medical therapy for isolated neuroaxis BRAF V600E–positive Langerhans cell histiocytosis management: illustrative case
por: Muthiah, Nallammai, et al.
Publicado: (2021)

Innate lymphoid cells are double‐edged swords under the mucosal barrier
por: Duan, Zhen, et al.
Publicado: (2021)

Impact of BRAF(V600E) mutation on aggressiveness and outcomes in adult clonal histiocytosis
por: Razanamahery, Jerome, et al.
Publicado: (2023)

Langerhans cell histiocytosis at the right mandible
por: Liu, Chia-Chi, et al.
Publicado: (2018)

Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis
por: Tóth, Béla, et al.
Publicado: (2020)

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation
por: Holst, Johanne Marie, et al.
Publicado: (2021)

BRAF- and MAP2K1-Negative Multisystem Langerhans Cell Histiocytosis in an Elderly Patient
por: Kothari, Rohit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ubcahr98ir2vb8j728diq8ee0t